Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-7
Closed -$665 2060
2023
Q4
$665 Hold
7
﹤0.01% 2015
2023
Q3
$654 Hold
7
﹤0.01% 1917
2023
Q2
$640 Buy
7
+6
+600% +$492 ﹤0.01% 1994
2023
Q1
$74 Sell
1
-5
-83% -$433 ﹤0.01% 2336
2022
Q4
$501 Buy
+6
New +$541 ﹤0.01% 2026

Other funds holding AMED

Advisornet Financial's AMED Position: Q1 2024 in Review

Advisornet Financial sold out of Amedisys (AMED) in Q1 2024, closing a stake of 7 shares — an estimated $665 sold.

Advisornet Financial first reported a position in AMED in Q4 2022 and held it in 5 quarters. The position peaked at $665 in Q4 2023. 283 funds tracked by Wall St. Rank hold AMED as of Q1 2024.

  • Advisornet Financial reported no remaining Amedisys position as of Q1 2024 after selling out during the quarter.
  • Advisornet Financial sold 7 Amedisys shares in Q1 2024, an estimated $665.
  • Advisornet Financial first reported a position in Amedisys in Q4 2022 and held it in 5 quarters.
  • Advisornet Financial's Amedisys position peaked at $665 in Q4 2023.
  • 283 funds tracked by Wall St. Rank held Amedisys as of Q1 2024.

Based on Advisornet Financial's 13F filing for Q1 2024, filed 12 Apr 2024.